The Conversation (0)
- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
This October, Coloplast will be launching a new flexible catheter for men. With this new product, Coloplast now has a complete range of catheters for all users. Coloplast will begin the roll-out of a new flexible male catheter next month. It adds further fuel to the company’s plans to outperform its competitors in the continence care market.
This October, Coloplast will be launching a new flexible catheter for men. With this new product, Coloplast now has a complete range of catheters for all users.
Coloplast will begin the roll-out of a new flexible male catheter next month.
Scheduled for launch on the company’s core markets in October, the new catheter is the latest addition to Coloplast’s innovative product portfolio and adds further fuel to the company’s plans to outperform its competitors in the continence care market.
The current growth rate in the global continence care market is 5 – 6 percent per year, and launching new products like the SpeediCath Flex is Coloplast’s recipe for outgrowing the rest of its competitors on the market.
“Our ambition is to continue to gain market share. To do that we need innovative products like the SpeediCath Flex. It is discreet, hygienic and easy to use,” said Kristian Villumsen, Executive VP of Coloplast’s Chronic Care business, which includes the Continence Care division.
As part of the SpeediCath range of male catheters, the SpeediCath Flex is available in both compact and traditional versions.
“By adding another catheter to our product catalogue, we help make life easier for even more users,” said Mr Villumsen.
Continence Care is Coloplast’s second-largest business area, accounting for some 35 percent of consolidated revenue. Coloplast’s other business areas are Ostomy Care, Wound & Skin Care, and Urology Care.
Facts
Scheduled for launch on the company’s core markets in October, the new catheter is the latest addition to Coloplast’s innovative product portfolio and adds further fuel to the company’s plans to outperform its competitors in the continence care market.
The current growth rate in the global continence care market is 5 – 6 percent per year, and launching new products like the SpeediCath Flex is Coloplast’s recipe for outgrowing the rest of its competitors on the market.
“Our ambition is to continue to gain market share. To do that we need innovative products like the SpeediCath Flex. It is discreet, hygienic and easy to use,” said Kristian Villumsen, Executive VP of Coloplast’s Chronic Care business, which includes the Continence Care division.
As part of the SpeediCath range of male catheters, the SpeediCath Flex is available in both compact and traditional versions.
“By adding another catheter to our product catalogue, we help make life easier for even more users,” said Mr Villumsen.
Continence Care is Coloplast’s second-largest business area, accounting for some 35 percent of consolidated revenue. Coloplast’s other business areas are Ostomy Care, Wound & Skin Care, and Urology Care.
Facts
- SpeediCath Flex will be rolled out in all major markets in 2016 and 2017.
- A special feature of the new product is its flexible tip and dry sleeve, which is a protective film that makes catheter insertion easy.
Read more: Coloplast.com/speedicath-Flex
Contact:
Maria Lindeberg
Senior Media Relations Manager
+45 49 11 30 95
dkmalg@coloplast.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.